These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31687861)

  • 1. Symptoms of mast cell activation syndrome in functional gastrointestinal disorders.
    Wilder-Smith CH; Drewes AM; Materna A; Olesen SS
    Scand J Gastroenterol; 2019 Nov; 54(11):1322-1325. PubMed ID: 31687861
    [No Abstract]   [Full Text] [Related]  

  • 2. The spectra, symptom profiles and overlap of Rome III functional gastrointestinal disorders in a tertiary center in South China.
    Xiong LS; Shi Q; Gong XR; Cui Y; Chen MH
    J Dig Dis; 2014 Oct; 15(10):538-44. PubMed ID: 25102919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The overlap of upper functional gastrointestinal disorders with irritable bowel syndrome in Chinese outpatients: A multicenter study.
    Yao X; Yang YS; Cui LH; Sun G; Peng LH; Wang WF; Hyder Q; Zhang XL
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1584-93. PubMed ID: 26875585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overlap of Irritable Bowel Syndrome and Functional Dyspepsia in the Clinical Setting: Prevalence and Risk Factors.
    von Wulffen M; Talley NJ; Hammer J; McMaster J; Rich G; Shah A; Koloski N; Kendall BJ; Jones M; Holtmann G
    Dig Dis Sci; 2019 Feb; 64(2):480-486. PubMed ID: 30368683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectra of functional gastrointestinal disorders diagnosed by Rome III integrative questionnaire in a Japanese outpatient office and the impact of overlapping.
    Nakajima S; Takahashi K; Sato J; Fukuda M; Yamamoto K; Inoue T; Okumura Y; Fujiyama Y
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S138-43. PubMed ID: 20586856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilising lipid and, arginine and proline metabolism in blood plasma to differentiate the biochemical expression in functional dyspepsia (FD) and irritable bowel syndrome (IBS).
    Karpe AV; Liu JW; Shah A; Koloski N; Holtmann G; Beale DJ
    Metabolomics; 2022 Jun; 18(6):38. PubMed ID: 35687195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for Local and Systemic Immune Activation in Functional Dyspepsia and the Irritable Bowel Syndrome: A Systematic Review.
    Burns G; Carroll G; Mathe A; Horvat J; Foster P; Walker MM; Talley NJ; Keely S
    Am J Gastroenterol; 2019 Mar; 114(3):429-436. PubMed ID: 30839392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there an association between GNbeta3-C825T genotype and lower functional gastrointestinal disorders?
    Andresen V; Camilleri M; Kim HJ; Stephens DA; Carlson PJ; Talley NJ; Saito YA; Urrutia R; Zinsmeister AR
    Gastroenterology; 2006 Jun; 130(7):1985-94. PubMed ID: 16762621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of functional dyspepsia in an outpatient clinic with primary care physicians in Japan.
    Okumura T; Tanno S; Ohhira M; Tanno S
    J Gastroenterol; 2010 Feb; 45(2):187-94. PubMed ID: 19997854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep Quality of Functional Gastrointestinal Disorder Patients in Class-Three Hospitals: A Cross-Sectional Study in Tianjin, China.
    Zhao W; Jin H; Xu M; Wang D; Liu Y; Tang Y; Zhang Q; Hua J; Wang B
    Biomed Res Int; 2018; 2018():3619748. PubMed ID: 29977909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenetic approach to the treatment of functional disorders of the gastrointestinal tract and their intersection: results of the Russian observation retrospective program COMFORT.
    Ivashkin VT; Poluektova EA; Glazunov AB; Putilovskiy MA; Epstein OI
    BMC Gastroenterol; 2019 Dec; 20(1):2. PubMed ID: 31892312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota profiles and the role of anti-CdtB and anti-vinculin antibodies in patients with functional gastrointestinal disorders (FGID).
    Vasapolli R; Schulz C; Schweden M; Casèn C; Kirubakaran GT; Kirste KH; Macke L; Link A; Schütte K; Malfertheiner P
    Eur J Clin Invest; 2021 Dec; 51(12):e13666. PubMed ID: 34390492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overlap between irritable bowel syndrome and functional dyspepsia including subtype analyses.
    Choi YJ; Kim N; Yoon H; Shin CM; Park YS; Kim JW; Kim YS; Lee DH; Jung HC
    J Gastroenterol Hepatol; 2017 Sep; 32(9):1553-1561. PubMed ID: 28160607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overlap of symptoms of gastroesophageal reflux disease, dyspepsia and irritable bowel syndrome in the general population.
    Rasmussen S; Jensen TH; Henriksen SL; Haastrup PF; Larsen PV; Søndergaard J; Jarbøl DE
    Scand J Gastroenterol; 2015 Feb; 50(2):162-9. PubMed ID: 25525975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast Cell Activation Syndrome and Gut Dysfunction: Diagnosis and Management.
    Hamilton MJ
    Curr Gastroenterol Rep; 2024 Apr; 26(4):107-114. PubMed ID: 38353900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herbal Preparation STW 5 for Functional Gastrointestinal Disorders: Clinical Experience in Everyday Practice.
    Lapina TL; Trukhmanov AS
    Dig Dis; 2017; 35 Suppl 1():30-35. PubMed ID: 29421814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Overlapping Functional Gastrointestinal Disorders on the Presentation and Quality of Life of Patients with Erosive Esophagitis and Nonerosive Reflux Disease.
    Lee SW; Chang CS; Lien HC; Peng YC; Wu CY; Yeh HZ
    Med Princ Pract; 2015; 24(5):491-5. PubMed ID: 26137901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that independent gut-to-brain and brain-to-gut pathways operate in the irritable bowel syndrome and functional dyspepsia: a 1-year population-based prospective study.
    Koloski NA; Jones M; Talley NJ
    Aliment Pharmacol Ther; 2016 Sep; 44(6):592-600. PubMed ID: 27444264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of psychiatric and extraintestinal comorbidity on quality of life and bowel symptom burden in functional GI disorders.
    Vu J; Kushnir V; Cassell B; Gyawali CP; Sayuk GS
    Neurogastroenterol Motil; 2014 Sep; 26(9):1323-32. PubMed ID: 25070610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of overlap syndromes and symptoms in pediatric functional dyspepsia.
    Friesen CA; Rosen JM; Schurman JV
    BMC Gastroenterol; 2016 Jul; 16(1):75. PubMed ID: 27457769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.